Is BioXcel Therapeutics Inc (BTAI) Good For Your Portfolio?
BioXcel Therapeutics Inc (NASDAQ:BTAI) saw a downside of -3.64% to close Friday at $2.91 after subtracting -$0.11 on the day. The 5-day average trading volume is 696,080 shares of the company’s common stock. It has gained $3.54 in the past week and touched a new high 1 time within the past 5 days. An average […]
Analysts From Major Brokerage Firms Release Report On BioXcel Therapeutics Inc. (BTAI)
The stock of BioXcel Therapeutics Inc. (NASDAQ:BTAI) increased by $0.13 on Friday to finish at $4.02, up 3.21 percent. The last five days have seen an average of 910,120 shares of common stock traded. 14 times new highs were reached in the current year, with a fall of -$17.46. The average number of shares traded […]
What Are Wall Street’s Thoughts On BioXcel Therapeutics Inc. Shares (BTAI)?
The stock of BioXcel Therapeutics Inc. (NASDAQ:BTAI) decreased by -$0.19 on Tuesday to finish at $4.14, down -4.39 percent. The last five days have seen an average of 3,229,400 shares of common stock traded. 14 times new highs were reached in the current year, with a fall of -$17.34. The average number of shares traded […]
BioXcel Therapeutics Inc. (BTAI): Here Are Some Research Recommendations
BioXcel Therapeutics Inc. (NASDAQ:BTAI) finished Friday with an addition of $0.01 to close at $7.40, an upside of 0.14 percent. An average of 859,960 shares of common stock have been traded in the last five days. There was a fall of -$0.11 in the past week, and it reached a new high 24 times over […]
